Langlois Mélanie, Richer Francois, Chouinard Sylvain
Unité des Troubles du Mouvement André-Barbeau, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Can J Neurol Sci. 2003 Mar;30 Suppl 1:S34-44. doi: 10.1017/s031716710000322x.
Dystonia is a syndrome of sustained muscular contractions with numerous underlying etiologies. This review examines the varied phenomenology of dystonias, its evolving classification including recent genetic data as well as its clinical investigation and treatment. Although age of onset, anatomical distribution and family history are key elements of the investigation of dystonia, classification increasingly relies on etiologic and genetic criteria. Physiological abnormalities in striato-cortical circuits are common in dystonia but the pathophysiology is still unclear. In recent years, a great deal has been learned on the more common primary dystonias such as primary torsion dystonia and on dystonia-plus syndromes such as dopamine responsive dystonia. Treatment of dystonia has also evolved and there are now a number of therapeutic agents with clear beneficial effects including anticholinergics, benzodiazepines, and botulinum toxin and there is growing interest in neurofunctional surgery including deep brain stimulation.
肌张力障碍是一种由多种潜在病因导致的持续性肌肉收缩综合征。本综述探讨了肌张力障碍的多样临床表现、其不断演变的分类(包括近期的遗传学数据)以及临床研究与治疗。尽管发病年龄、解剖学分布和家族史是肌张力障碍调查的关键要素,但分类越来越依赖病因学和遗传学标准。纹状体 - 皮质回路的生理异常在肌张力障碍中很常见,但病理生理学仍不清楚。近年来,人们对更常见的原发性肌张力障碍(如原发性扭转性肌张力障碍)以及肌张力障碍叠加综合征(如多巴胺反应性肌张力障碍)有了很多了解。肌张力障碍的治疗也有所发展,现在有多种具有明确有益效果的治疗药物,包括抗胆碱能药物、苯二氮䓬类药物和肉毒杆菌毒素,并且对神经功能手术(包括深部脑刺激)的兴趣也在增加。